InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-31.0%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Browse the full record of transactions filed by Schwartz Elissa J., 董事. Insider active across 1 company, notably Galectin Therapeutics INC. In total, 1 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €2k. Activity tracked since 21 January 2022. The latest transaction was filed on 21 January 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Schwartz Elissa J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报1 总计
1,000 股@ US$2.00100.0% 占其流量Common StockSEC:0001133416-22-000012:0
标准退出：2022年4月21日 (T+90)
1 条申报中的 1 条
About Schwartz Elissa J.
Elissa J. Schwartz is a Director at GALECTIN THERAPEUTICS INC. She is involved in strategic decision-making and overseeing the company's activities. Her experience and knowledge of the industry are valuable assets in guiding GALECTIN THERAPEUTICS towards its goals.
